Sensome Real-time, in situ Lung Tumor Confirmation System Study Enrols First Patients

French microsensing technology pioneer, Sensome has announced that the first eight patients have been enrolled in the first-in-human INSPECT study … continue reading "Sensome Real-time, in situ Lung Tumor Confirmation System Study Enrols First Patients"

The post Sensome Real-time, in situ Lung Tumor Confirmation System Study Enrols First Patients appeared first on Medlatest - Medical Device News.